Clinical Research Directory
Browse clinical research sites, groups, and studies.
Long-term Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Ulcerative Colitis
Sponsor: Seoul National University Hospital
Summary
This study aims to perform fecal microbiota transplantation (FMT) and analyze its effects in selected patients aged between 10 and 80 years who have been diagnosed with ulcerative colitis and have been receiving treatment for more than three months at Seoul National University Hospital, Seoul National University Boramae Medical Center, and Seoul National University Bundang Hospital. Through this analysis, the study seeks to identify the long-term efficacy of FMT as a treatment for ulcerative colitis, evaluate the safety of the procedure, and establish a foundation for personalized FMT based on gut microbiota analysis.
Key Details
Gender
All
Age Range
10 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2023-07-19
Completion Date
2027-06-30
Last Updated
2025-09-12
Healthy Volunteers
No
Interventions
Fecal microbiota transplantation (FMT)
Fecal microbiota transplantation (FMT) will be performed at weeks 0 and 4 of study enrollment by administering approximately 250-300 cc of a multi-donor fecal suspension into the colon via sigmoidoscopy, colonoscopy, or by oral administration of an equivalent amount (4 capsules).
Locations (1)
Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine
Seoul, Dongjak-gu, South Korea